TABLE 3.
RRs of non-Hodgkin lymphoma, multiple myeloma, and leukemia by categories of aspartame intake in men in the HPFS and in women in the NHS, 1994–20061
|
Aspartame2 |
|||||||
| Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | Quartile 5 | P-trend3 | P-heterogeneity4 | |
| Range (mg/d) | |||||||
| Men | 0 | <19 | 19–59 | 60–142 | ≥143 | — | — |
| Women | 0 | <19 | 19–55 | 56–128 | ≥129 | — | — |
| Person-years (thousands) | |||||||
| Men | 100.4 | 58.3 | 57.6 | 57.6 | 58.6 | — | — |
| Women | 224.8 | 147.0 | 147.0 | 147.7 | 147.6 | — | — |
| Non-Hodgkin lymphoma | |||||||
| Men | |||||||
| Cases (n) | 95 | 55 | 65 | 49 | 69 | — | — |
| Simple model | 1.00 (—)5 | 0.93 (0.66, 1.30) | 1.15 (0.83, 1.58) | 0.98 (0.69, 1.38) | 1.59 (1.15, 2.19) | 0.002 | — |
| Multivariable | 1.00 (—) | 0.92 (0.65, 1.29) | 1.13 (0.82, 1.57) | 0.98 (0.68, 1.40) | 1.64 (1.17, 2.29) | 0.002 | — |
| Women | |||||||
| Cases (n) | 172 | 114 | 110 | 91 | 86 | — | — |
| Simple model | 1.00 (—) | 0.97 (0.76, 1.23) | 0.99 (0.78, 1.26) | 0.87 (0.67, 1.12) | 0.95 (0.73, 1.24) | 0.61 | — |
| Multivariable | 1.00 (—) | 0.94 (0.74, 1.20) | 0.96 (0.75, 1.22) | 0.83 (0.64, 1.08) | 0.91 (0.69, 1.20) | 0.48 | — |
| Pooled | |||||||
| Multivariable | 1.00 (—) | 0.93 (0.76, 1.13) | 1.02 (0.83, 1.24) | 0.88 (0.71, 1.09) | 1.16 (0.93, 1.43)6 | 0.12 | 0.006 |
| Multiple myeloma | |||||||
| Men | |||||||
| Cases (n) | 10 | 17 | 11 | 14 | 13 | — | — |
| Simple model | 1.00 (—) | 2.80 (1.26, 6.20) | 1.62 (0.67, 3.92) | 2.56 (1.13, 5.84) | 2.85 (1.23, 6.62) | 0.07 | — |
| Multivariable | 1.00 (—) | 3.33 (1.48, 7.49) | 1.70 (0.68, 4.23) | 2.96 (1.25, 6.96) | 3.36 (1.38, 8.19) | 0.05 | — |
| Women | |||||||
| Cases (n) | 45 | 14 | 25 | 25 | 15 | ||
| Simple model | 1.00 (—) | 0.43 (0.23, 0.78) | 0.82 (0.50, 1.34) | 0.89 (0.54, 1.45) | 0.61 (0.34, 1.11) | 0.47 | — |
| Multivariable | 1.00 (—) | 0.40 (0.22, 0.74) | 0.76 (0.46, 1.27) | 0.83 (0.50, 1.39) | 0.59 (0.32, 1.09) | 0.48 | — |
| Pooled | |||||||
| Multivariable | 1.00 (—) | 0.86 (0.53, 1.41)6 | 0.92 (0.59, 1.44) | 1.16 (0.75, 1.81)6 | 1.03 (0.62, 1.72)6 | 0.44 | 0.049 |
| Leukemia | |||||||
| Men | |||||||
| Cases (n) | 23 | 14 | 23 | 19 | 18 | — | — |
| Simple model | 1.00 (—) | 0.88 (0.45, 1.73) | 1.62 (0.89, 2.93) | 1.56 (0.84, 2.90) | 1.68 (0.89, 3.17) | 0.07 | — |
| Multivariable | 1.00 (—) | 0.89 (0.45, 1.77) | 1.69 (0.91, 3.12) | 1.55 (0.81, 2.94) | 1.56 (0.79, 3.06) | 0.17 | — |
| Women | |||||||
| Cases (n) | 34 | 21 | 32 | 21 | 21 | ||
| Simple model | 1.00 (—) | 0.88 (0.51, 1.51) | 1.45 (0.89, 2.36) | 1.06 (0.61, 1.84) | 1.29 (0.74, 2.25) | 0.36 | — |
| Multivariable | 1.00 (—) | 0.85 (0.48, 1.48) | 1.34 (0.81, 2.21) | 0.95 (0.54, 1.66) | 1.04 (0.58, 1.85) | 0.94 | — |
| Pooled | |||||||
| Multivariable | 1.00 (—) | 0.86 (0.56, 1.33) | 1.47 (1.00, 2.17) | 1.17 (0.77, 1.79) | 1.23 (0.80, 1.91) | 0.31 | 0.35 |
Cox proportional hazards models were used to compute RRs (95% CIs) and P-trend values. Heterogeneity between main results for men and women was tested by using the random-effects method of DerSimonian and Laird (22). Simple model values were adjusted for age and questionnaire cycle. Multivariable values were adjusted for age; questionnaire cycle; total sugar intake; fruit and vegetable consumption; multivitamin use; intakes of alcohol, saturated fat, animal protein, and total energy; race; BMI; height; discretionary physical activity; smoking history; and menopausal status and use of hormone replacement therapy (women only). HPFS, Health Professionals Follow-Up Study; NHS, Nurses’ Health Study.
Aspartame intake was from diet soda and packets used at the table; categories are for zero intake plus quartiles of intakes greater than zero.
Test for linear trend by using median values within each category of aspartame intake.
Test for heterogeneity between linear models for men and women.
RR; 95% CI in parentheses (all such values).
< 0.05 in the test for heterogeneity between RRs for men and women in the same aspartame category.